Survival of atherosclerotic patients as related to oxidative stress and gene polymorphisms

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 621, Issue 1-2, 2007, Pages 119-128

  Izzotti, Alberto ^a   Piana, Antonietta ^a   Minniti, Giuseppe ^a   Vercelli, Marina ^a   Perrone, Lucia ^b   De Flora, Silvio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b GALLIERA HOSPITAL   (Italy)

Author keywords

Atherosclerosis; Gene polymorphisms; Oxidative stress; Survival

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA GLYCOSYLTRANSFERASE; GLUTATHIONE; HOMOCYSTEINE; MALONALDEHYDE; PROTHROMBIN;

AORTA; ARTICLE; ATHEROSCLEROSIS; FOLLOW UP; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DNA DAMAGE; FOLLOW-UP STUDIES; GLUTATHIONE; HOMOCYSTEINE; HUMANS; KAPLAN-MEIERS ESTIMATE; OXIDATIVE STRESS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES;

EID: 34447292992     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.12.012     Document Type: Article

References (38)

1. World Health Organization. Classification of atherosclerotic lesions. WHO Tech. Rep. Serv. 143 (1985) 1-20
2. Ross R. Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. Am. J. Pathol. 143 (1993) 987-1002
3. De Flora S., Izzotti A., Randerath K., Randerath E., Bartsch H., Nair J., Balansky R., van Schooten F., Degan P., Fronza G., Walsh D., and Lewtas J. DNA adducts and chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutat. Res. 366 (1996) 197-238
4. Benditt E.P., and Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. U.S.A. 70 (1973) 1753-1756
5. Trosko J., and Chang C. An integrative hypothesis linking cancer, diabetes and atherosclerosis: The role of mutations and epigenetic changes. Med. Hypoth. 6 (1980) 455-468
6. Penn A., Garte S.J., Warren L., Nesta D., and Mindich B. Transforming gene in human atherosclerotic plaque DNA. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 7951-7955
7. B.A. Bridges, D.E. Bowyer, E.S. Hansen, A. Penn, K. Wakabayashi (Eds.), Report of ICPEMC Subcommittee 7/1, The possible involvement of somatic mutations in the development of atherosclerotic plaques (special issue), Mutat. Res. 239 (1990) 143-187.
8. De Flora S., Izzotti A., Walsh D., Degan P., Petrilli G.L., and Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J. 11 (1997) 1021-1031
9. Izzotti A., Cartiglia C., Lewtas J., and De Flora S. Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J. 15 (2001) 752-757
10. Bogliolo M., Izzotti A., De Flora S., Carli C., Abbondandolo A., and Degan P. Detection of the "4977 bp" mitochondrial DNA deletion in human atherosclerotic lesions. Mutagenesis 14 (1999) 77-82
11. Izzotti A., Saccà S.C., Cartiglia C., and De Flora S. Oxidative DNA damage in the eye of glaucoma patients. Am. J. Med. 114 (2003) 638-646
12. Bell D.A., Badawi A.F., Lang N.P., Ilett K.F., Kadlubar F.F., and Hirvonen A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res. 55 (1995) 5226-5229
13. Deitz A.C., Zheng W., Leff M.A., Gross M., Wen W.Q., Doll M.A., Xiao G.H., Folsom A.R., and Hein D.W. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 905-910
14. Malinow M.R., Duell P.B., Hess D.L., Anderson P.H., Kruger W.D., Phillipson B.E., Gluckman R.A., Block P.C., and Upson B.M. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N. Engl. J. Med. 338 (1998) 1009-1015
15. De Stefano V., Martinelli I., Mannucci P.M., Paciaroni K., Chiusolo P., Casorelli I., Rossi E., and Leone G. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N. Engl. J. Med. 341 (1999) 801-806
16. Minniti G., Piana A., and Armani U. Determination of plasma and serum homocysteine by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 828 (1998) 401-405
17. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
18. Nair J., De Flora S., Izzotti A., and Bartsch H. Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions. Mutat. Res. : Fundam. Mol. Mech. Mutagen 621 (2007) 95-105
19. Balansky R., Izzotti A., Scatolini L., D'Agostini F., and De Flora S. Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Res. 56 (1996) 1642-1647
20. Chao C.L., Tsai H.H., Lee C.M., Hsu S.M., Kao J.T., Chien K.L., Sung F.C., and Lee Y.T. The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis 147 (1999) 379-386
21. Bianchi G., Brizi M., Rossi B., Ronchi M., Grossi G., and Marchesini G. Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis. Metabolism 49 (2000) 1434-1439
22. Cybulsky M.I., Won D., and Haidari M. Leukocyte recruitment to atherosclerotic lesions. Can. J. Cardiol. 20 (2004) 24-28
23. Binkova B., Smerhovsky Z., Strejc P., Boubelik O., Stavkova Z., Chvatalova I., and Sram R.J. DNA-adducts and atheroclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat. Res. 501 (2002) 115-128
24. Ilett K.F., Castleden W.M., Vandongen Y.K., Stacey M.C., Butler M.A., and Kadlubar F.F. Acetylation phenotype and cytochrome P450IA2 phenotype are unlikely to be associated with peripheral arterial disease. Clin. Pharamacol. Ther. 54 (1993) 317-322
25. Weisberg I.S., Jacques P.F., Selhub J., Bostom A.G., Chen Z., Curtis Ellison R., Eckfeldt J.H., and Rozen R. The 1298A → C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 156 (2001) 409-415
26. Liguria R. Trends and geographical distribution of mortality in Ligury in the 1988-1999 period (in Italian). Bollettino Regionale di Statistica 7 (2003) 21-46
27. In: Marmot M., and Eliott P. (Eds). Coronary Heart Diseases Epidemiology. From Aetiology to Public Health. second ed. (2005), Oxford University Press, Oxford, UK 932
28. Izzotti A., Camoirano A., Cartiglia C., Tampa E., and De Flora S. Formation of DNA adducts in the aorta of smoke-exposed rats. Modulation by five chemopreventive agents. Mutat. Res. 494 (2001) 97-106
29. Izzotti A., Balansky R.M., D'Agostini F., Bennicelli C., Myers S.R., Grubbs C.J., Lubet R.A., Kelloff G.J., and De Flora S. Modulation of biomarkers by chemopreventive agents in smoke exposed rats. Cancer Res. 61 (2001) 2472-2479
30. Izzotti A., Bagnasco M., Cartiglia C., Longobardi M., Camoirano A., Tampa E., Lubet R.A., and De Flora S. Modulation of multigene expression and proteome profiles by chemopreventive agents. Mutat. Res. 591 (2005) 212-223
31. Hsieh S.D., Yoshinaga H., Muto T., and Sakurai Y. Regular physical activity and coronary risk factors in Japanese men. Circulation 97 (1998) 661-665
32. Randerath K., Putman K.L., Osterburg H.H., Johnson S.A., Morgan D.G., and Finch C.E. Age-dependent increases of DNA adducts (I-compounds) in human and rat brain DNA. Mutat. Res. 295 (1993) 11-18
33. Elosua R., Molina L., Fito M., Arquer A., Sanchez-Quesada J.L., Covas M.I., Ordonez-Llanos J., and Marrugat J. Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis 167 (2003) 327-334
34. Manfredi S., Federici C., Picano E., Botto N., Rizza A., and Andreassi M.G. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artey disease: a case-only study. Mutat. Res. : Fundam. Mol. Mech. Mutagen. 621 (2007) 106-112
35. Wilson M.H., Grant P.J., Hardie L.J., and Wild C.P. Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J. 14 (2000) 791-796
36. Wilson M.H., Grant P.J., Kain K., Warner D.P., and Wild C.P. Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1. Biomarkers 8 (2003) 43-50
37. Salama S.A., Au W.W., Hunter G.C., Sheahan R.G., Badary O.A., Abdel-Naim A.B., and Hamada F.M. Polymorphic metabolizing genes and susceptibility to atherosclerosis among cigarette smokers. Environ. Mol. Mutagen. 40 (2002) 153-160
38. Li R., Folsom A.R., Sharrett A.R., Couper D., Bray M., and Tyroler H.A. Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 154 (2001) 729-738